EP Biocomposites (BOM:543595) EBITDA: ₹23.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543595 EP Biocomposites Ltd BOM:543595
76 GF Score
Price ₹106.00
GF Value ₹201.91
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is EP Biocomposites EBITDA?

EP Biocomposites BOM:543595 76 EBITDA is ₹23.8 Mil as of Mar. 2026. GuruFocus rates BOM:543595 with a GF Score™ of 76/100 and a GF Value™ of ₹201.91 (Significantly Undervalued). The stock has 6 warning signs investors should review.

EP Biocomposites's EBITDA for the six months ended in Mar. 2026 was ₹20.6 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹23.8 Mil.

During the past 12 months, the average EBITDA Growth Rate of EP Biocomposites was 26.20% per year. During the past 3 years, the average EBITDA Growth Rate was 28.70% per year. During the past 5 years, the average EBITDA Growth Rate was 31.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 8 years, the highest 3-Year average EBITDA Growth Rate of EP Biocomposites was 195.90% per year. The lowest was 10.70% per year. And the median was 41.50% per year.

EP Biocomposites's EBITDA per Share for the six months ended in Mar. 2026 was ₹12.25. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹14.14.

During the past 12 months, the average EBITDA per Share Growth Rate of EP Biocomposites was 26.20% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 22.80% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 8 years, the highest 3-Year average EBITDA per Share Growth Rate of EP Biocomposites was 210.20% per year. The lowest was 10.70% per year. And the median was 38.55% per year.

EP Biocomposites  (BOM:543595) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


EP Biocomposites EBITDA Related Terms


EP Biocomposites EBITDA Historical Data

* Premium members only.

The historical data trend for EP Biocomposites's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EP Biocomposites EBITDA Chart

EP Biocomposites Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA
Get a 7-Day Free Trial 13.88 11.17 17.06 18.84 23.78

EP Biocomposites Semi-Annual Data
Mar19 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.50 5.35 13.50 3.17 20.61

BOM:543595 vs TT, JCI, CARR: EBITDA Comparison

For the Building Products & Equipment subindustry, EP Biocomposites's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EP Biocomposites EV-to-EBITDA vs Construction Industry

For the Construction industry and Industrials sector, EP Biocomposites's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where EP Biocomposites's EV-to-EBITDA falls into.


BOM:543595
76GF Score
EP Biocomposites Ltd BOM:543595
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

EP Biocomposites's EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

EP Biocomposites's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2026, EP Biocomposites's EBITDA was ₹23.8 Mil.

EP Biocomposites's EBITDA for the quarter that ended in Mar. 2026 is calculated as

EP Biocomposites's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, EP Biocomposites's EBITDA was ₹20.6 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹23.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of ₹23.8 Mil mean?
EP Biocomposites (BOM:543595) has a EBITDA of ₹23.8 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on EP Biocomposites.
Is EP Biocomposites' EBITDA too high?
EP Biocomposites' current EBITDA is ₹23.8 Mil. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' EBITDA compare to TT and JCI?
EP Biocomposites' EBITDA of ₹23.8 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Construction company?
A good EBITDA depends on the Construction industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on EP Biocomposites. EP Biocomposites's current EBITDA is ₹23.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹201.91, compared to a current price of ₹106.00 — trading 47.5% below its estimated fair value. The current EBITDA is ₹23.8 Mil. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current EBITDA is ₹23.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EP Biocomposites (BOM:543595) Overvalued in 2026?

Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued. The current stock price of ₹106.00 is trading 47.5% below its estimated GF Value™ of ₹201.91. GuruFocus considers EP Biocomposites to be Significantly Undervalued.

Key valuation signals for BOM:543595:

  • EBITDA: ₹23.8 Mil
  • GF Value™: ₹201.91 vs. price of ₹106.00 (47.5% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EP Biocomposites Business Description

Address 1st Floor, B.R. Commercial Centre, Opposite Parade Grounds, Campal, Panaji, GA, IND, 403001
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score

Get the complete analysis for BOM:543595

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹106.00
Price
₹201.91
GF Value